# VKTX (Viking Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Viking Therapeutics, Inc. reported $0 in revenue and a net loss of $627.2M for the trailing twelve months ended September 30, 2026.

- Canonical: https://convexityos.com/fundamentals/VKTX
- Markdown: https://convexityos.com/fundamentals/VKTX.md
- SEC CIK: 0001607678
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:18 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001607678&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $0 | Sep 30, 2026 |
| Operating Income | TTM | -$648.6M | Operating profit |
| Net Income | TTM | -$627.2M | GAAP bottom line |
| Diluted EPS | TTM | -$5.31 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $959.8M | Total debt: $4.04M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & Development | $345.0M | $101.6M | $63.81M | $54.23M | $44.98M | $31.93M | $23.56M | $19.04M | $13.74M | $9.00M |
| Total Operating Expenses | $393.3M | $150.9M | $100.8M | $70.36M | $55.68M | $42.66M | $32.69M | $26.16M | $19.07M | $13.85M |
| **Operating Income** | -$393.3M | -$150.9M | -$100.8M | -$70.36M | -$55.68M | -$42.66M | -$32.69M | -$26.16M | -$19.07M | -$13.85M |
| Income Before Tax | -$359.6M | -$110.0M | -$85.89M | -- | -- | -- | -- | -- | -- | -- |
| Income Tax Expense | $1.0K | $1.0K | $1.0K | $1.0K | $2.0K | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$359.6M | -$110.0M | -$85.89M | -$68.87M | -$54.99M | -$39.49M | -$25.78M | -$22.06M | -$20.58M | -$14.73M |
| Basic EPS | -$3.19 | -$1.01 | -$0.91 | -$0.90 | -$0.71 | -$0.54 | -$0.36 | -$0.38 | -$0.79 | -$0.90 |
| **Diluted EPS** | -$3.19 | -$1.01 | -$0.91 | -$0.90 | -$0.71 | -$0.54 | -$0.36 | -$0.38 | -$0.79 | -$0.90 |
| Basic Shares Outstanding | 112.7M | 109.0M | 94.3M | 76.8M | 77.2M | 72.6M | 72.0M | 57.6M | 26.0M | 16.3M |
| Diluted Shares Outstanding | 112.7M | 109.0M | 94.3M | 76.8M | 77.2M | 72.6M | 72.0M | 57.6M | 26.0M | 16.3M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & Development | $166.8M | $115.8M | $150.2M | $153.5M | $89.95M | $60.15M | $41.39M | $30.99M |
| Total Operating Expenses | $187.1M | $132.6M | $164.1M | $164.7M | $98.56M | $74.57M | $55.47M | $46.24M |
| **Operating Income** | -$187.1M | -$132.6M | -$164.1M | -$164.7M | -$98.56M | -$74.57M | -$55.47M | -$46.24M |
| Interest Income | $4.01M | -- | -- | -- | $7.77M | -- | -- | -- |
| Interest Expense | $88K | -- | -- | -- | $0 | -- | -- | -- |
| **Net Income** | -$183.2M | -$128.0M | -$158.3M | -$157.7M | -$90.79M | -$65.56M | -$45.63M | -$35.42M |
| Basic EPS | -$1.55 | -$1.10 | -$1.37 | -- | -$0.81 | -$0.58 | -$0.41 | -- |
| **Diluted EPS** | -$1.55 | -$1.10 | -$1.37 | -- | -$0.81 | -$0.58 | -$0.41 | -- |
| Basic Shares Outstanding | 118.0M | 116.3M | 115.6M | -- | 112.3M | 112.1M | 112.1M | -- |
| Diluted Shares Outstanding | 118.0M | 116.3M | 115.6M | -- | 112.3M | 112.1M | 112.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $165.8M | $26.68M | $55.52M | $36.63M | $26.37M | $29.12M | $8.38M | $24.78M | $8.99M | $3.08M |
| Short-Term Investments | $539.9M | $875.9M | $306.6M | $118.9M | $175.7M | $219.3M | $267.3M | $276.7M | $11.59M | -- |
| **Cash & Short-Term Investments** | $705.7M | $902.6M | $362.1M | $155.5M | $202.1M | $248.4M | $275.6M | $301.5M | $20.57M | $3.08M |
| **Total Current Assets** | $715.6M | $907.2M | $367.2M | $167.0M | $210.5M | $256.1M | $283.5M | $302.1M | $21.85M | $13.97M |
| **Total Non-Current Assets** | $131K | $1.10M | $1.26M | $1.49M | $134K | $398K | $755K | $179K | $270K | $561K |
| **Total Assets** | $715.7M | $908.3M | $368.5M | $168.5M | $210.7M | $256.5M | $284.3M | $302.3M | $22.12M | $14.54M |
| Accounts Payable | $53.25M | $9.81M | $7.51M | $8.53M | $1.44M | $3.99M | $2.43M | $959K | $1.53M | $1.20M |
| **Total Current Liabilities** | $76.67M | $27.41M | $19.14M | $21.95M | $8.78M | $12.13M | $6.78M | $4.55M | $8.66M | $6.48M |
| **Total Non-Current Liabilities** | $0 | $630K | $936K | $1.26M | $0 | $29K | $360K | $12K | $0 | $16K |
| **Total Liabilities** | $76.67M | $28.04M | $20.07M | $23.21M | $8.78M | $12.16M | $7.14M | $4.56M | $8.66M | $6.49M |
| **Total Debt (incl. Leases)** | $137K | $1.12M | $1.26M | $1.56M | $29K | $359K | $662K | -- | -- | -- |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $358 | $208 |
| Retained Earnings | -$847.5M | -$487.9M | -$377.9M | -$292.0M | -$223.2M | -$168.2M | -$128.7M | -$102.9M | -$80.86M | -$60.28M |
| **Total Stockholders' Equity** | $639.1M | $880.3M | $348.4M | $145.3M | $201.9M | $244.3M | $277.1M | $297.8M | $13.46M | $8.04M |
| Total Equity | $639.1M | $880.3M | $348.4M | $145.3M | $201.9M | $244.3M | $277.1M | $297.8M | $13.46M | $8.04M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $677.6M | $125.8M | $118.1M | $165.8M | $100.4M | $33.88M | $37.94M | $26.68M |
| Short-Term Investments | $282.2M | $375.9M | $484.8M | $539.9M | $614.2M | $773.8M | $813.9M | $875.9M |
| **Cash & Short-Term Investments** | $959.8M | $501.7M | $603.0M | $705.7M | $714.6M | $807.7M | $851.9M | $902.6M |
| **Total Current Assets** | $973.0M | $517.6M | $608.2M | $715.6M | $738.7M | $827.0M | $866.0M | $907.2M |
| **Total Non-Current Assets** | $4.17M | $4.33M | $33K | $131K | $712K | $834K | $970K | $1.10M |
| **Total Assets** | $977.2M | $521.9M | $608.2M | $715.7M | $739.4M | $827.9M | $867.0M | $908.3M |
| Accounts Payable | $82.13M | $69.01M | $67.18M | $53.25M | $4.41M | $5.49M | $7.70M | $9.81M |
| **Total Current Liabilities** | $133.9M | $109.7M | $106.3M | $76.67M | $26.07M | $31.98M | $19.57M | $27.41M |
| **Total Non-Current Liabilities** | $254.7M | $3.92M | $0 | $0 | $318K | $410K | $502K | $630K |
| **Total Liabilities** | $388.6M | $113.6M | $106.3M | $76.67M | $26.39M | $32.39M | $20.07M | $28.04M |
| **Total Debt (incl. Leases)** | $4.04M | $4.09M | -- | $137K | $755K | $878K | $1.00M | $1.12M |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K |
| Retained Earnings | -$1.32B | -$1.13B | -$1.01B | -$847.5M | -$689.9M | -$599.1M | -$533.5M | -$487.9M |
| **Total Stockholders' Equity** | $588.6M | $408.3M | $501.9M | $639.1M | $713.0M | $795.5M | $846.9M | $880.3M |
| Total Equity | $588.6M | $408.3M | $501.9M | $639.1M | $713.0M | $795.5M | $846.9M | $880.3M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$359.6M | -$110.0M | -$85.89M | -$68.87M | -$54.99M | -$39.49M | -$25.78M | -$22.06M | -$20.58M | -$14.73M |
| Stock-Based Compensation | $40.82M | $29.71M | $16.75M | $8.67M | $6.10M | $5.82M | $3.74M | $2.61M | $1.45M | $1.79M |
| Change in Payables | $43.44M | $2.30M | -$1.02M | $7.08M | -$2.54M | $1.55M | $1.47M | -$508K | $264K | $677K |
| **Operating Cash Flow** | -$278.7M | -$87.79M | -$73.38M | -$48.40M | -$47.59M | -$21.78M | -$24.75M | -$18.75M | -$14.76M | -$11.07M |
| Purchases of Investments | -$418.0M | -$1.11B | -$478.3M | -$121.4M | -$168.0M | -$280.6M | -$362.4M | -$348.2M | -$22.53M | -$16.92M |
| Sales & Maturities of Investments | $759.4M | $560.0M | $299.2M | $176.2M | $206.0M | $322.2M | $369.9M | $82.47M | $20.80M | $19.95M |
| **Investing Cash Flow** | $341.4M | -$553.4M | -$179.1M | $54.75M | $37.96M | $41.57M | $7.46M | -$265.7M | -$1.73M | $3.03M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $296.6M | $22.35M | $11.55M |
| Share Repurchases | -- | -- | -- | -$6.79M | -- | -- | -- | -- | -- | -$229 |
| **Financing Cash Flow** | $76.44M | $612.5M | $271.4M | $4.16M | $6.88M | $950K | $887K | $300.3M | $22.40M | $10.35M |
| **Net Change in Cash** | $139.1M | -$28.69M | $18.91M | $10.52M | -$2.75M | $20.74M | -$16.40M | $15.79M | $5.91M | $2.31M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$183.2M | -$128.0M | -$158.3M | -$157.7M | -$90.79M | -$65.56M | -$45.63M | -$35.42M |
| Stock-Based Compensation | $17.89M | $11.13M | $10.34M | $8.59M | $7.34M | $13.55M | $11.35M | $5.67M |
| Change in Payables | $13.12M | $1.83M | $13.93M | $48.84M | -$1.08M | -$2.21M | -$2.11M | $9.56M |
| **Operating Cash Flow** | -$138.2M | -$125.2M | -$114.0M | -$85.29M | -$94.00M | -$47.06M | -$52.33M | -$31.18M |
| Purchases of Investments | -$12.28M | -$70.05M | -$72.44M | -$40.49M | -$21.45M | -$123.5M | -$232.6M | -$137.0M |
| Sales & Maturities of Investments | $104.8M | $141.0M | $126.6M | $116.1M | $181.5M | $166.0M | $295.9M | $143.5M |
| **Investing Cash Flow** | $92.52M | $109.4M | $54.19M | $75.61M | $160.0M | $42.51M | $63.24M | $6.58M |
| **Financing Cash Flow** | $597.6M | $23.59M | $12.08M | $75.10M | $480K | $507K | $349K | $1.00M |
| **Net Change in Cash** | $551.9M | $7.84M | -$47.71M | $65.42M | $66.50M | -$4.05M | $11.26M | -$23.60M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -56.3% | -12.5% | -24.7% | -47.4% | -27.2% | -16.2% | -9.3% | -7.4% | -152.8% | -183.2% |
| Return on Assets (ROA) | -50.2% | -12.1% | -23.3% | -40.9% | -26.1% | -15.4% | -9.1% | -7.3% | -93.0% | -101.3% |
| Current Ratio | 9.33x | 33.09x | 19.19x | 7.61x | 23.98x | 21.12x | 41.83x | 66.40x | 2.52x | 2.16x |
| Quick Ratio | 9.21x | 32.93x | 18.92x | 7.08x | 23.02x | 20.48x | 40.67x | 66.27x | 2.38x | 0.47x |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.01x | 0.00x | 0.00x | 0.00x | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -106.6% | -131.0% | -94.1% | -56.3% | -33.3% | -21.6% | -15.1% | -12.5% |
| Return on Assets (ROA) | -64.2% | -102.5% | -77.7% | -50.2% | -32.1% | -20.7% | -14.8% | -12.1% |
| Current Ratio | 7.27x | 4.72x | 5.72x | 9.33x | 28.34x | 25.86x | 44.25x | 33.09x |
| Quick Ratio | 7.17x | 4.57x | 5.67x | 9.21x | 27.41x | 25.26x | 43.52x | 32.93x |
| Debt to Equity | 0.01x | 0.01x | -- | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
